[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP1901718A4 - Compositions de ticlopidine à diffusion modifiée - Google Patents

Compositions de ticlopidine à diffusion modifiée

Info

Publication number
EP1901718A4
EP1901718A4 EP06772777A EP06772777A EP1901718A4 EP 1901718 A4 EP1901718 A4 EP 1901718A4 EP 06772777 A EP06772777 A EP 06772777A EP 06772777 A EP06772777 A EP 06772777A EP 1901718 A4 EP1901718 A4 EP 1901718A4
Authority
EP
European Patent Office
Prior art keywords
ticlopidine
compositions
modified release
release
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06772777A
Other languages
German (de)
English (en)
Other versions
EP1901718A1 (fr
Inventor
Gary Liversidge
Scott Jenkins
Paul Stark
Niall Fanning
Gurvinder Rekhi
John Devane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharma International Ltd
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/372,857 external-priority patent/US20060240105A1/en
Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd
Publication of EP1901718A1 publication Critical patent/EP1901718A1/fr
Publication of EP1901718A4 publication Critical patent/EP1901718A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06772777A 2005-06-13 2006-06-09 Compositions de ticlopidine à diffusion modifiée Withdrawn EP1901718A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68993105P 2005-06-13 2005-06-13
US11/372,857 US20060240105A1 (en) 1998-11-02 2006-03-10 Multiparticulate modified release composition
PCT/US2006/022597 WO2007011473A1 (fr) 2005-06-12 2006-06-09 Compositions de ticlopidine à diffusion modifiée

Publications (2)

Publication Number Publication Date
EP1901718A1 EP1901718A1 (fr) 2008-03-26
EP1901718A4 true EP1901718A4 (fr) 2012-07-18

Family

ID=37670856

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06772777A Withdrawn EP1901718A4 (fr) 2005-06-13 2006-06-09 Compositions de ticlopidine à diffusion modifiée

Country Status (5)

Country Link
EP (1) EP1901718A4 (fr)
CA (1) CA2611938A1 (fr)
DE (1) DE112006001548T5 (fr)
ES (1) ES2326251B1 (fr)
WO (1) WO2007011473A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008213744B2 (en) * 2007-02-09 2013-12-05 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
WO2008115820A1 (fr) * 2007-03-16 2008-09-25 Elan Corporation Plc Combinaison d'un analgésique narcotique et non narcotique
CA2936740C (fr) 2014-10-31 2017-10-10 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
BR112020013374A2 (pt) * 2017-12-29 2020-12-01 Exentis Knowledge Gmbh sistema de administração de medicamentos
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051141A (en) * 1973-02-01 1977-09-27 Centre D'etudes Pour L'industrie Pharmaceutique Thieno[3,2-c]pyridine derivatives
EP1005864A1 (fr) * 1998-11-30 2000-06-07 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Compositions pharmaceutiques stables dépourvues d'antioxidant contenant des dérivés thiènopyridine
US20050053660A1 (en) * 2001-01-31 2005-03-10 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051141A (en) * 1973-02-01 1977-09-27 Centre D'etudes Pour L'industrie Pharmaceutique Thieno[3,2-c]pyridine derivatives
EP1005864A1 (fr) * 1998-11-30 2000-06-07 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Compositions pharmaceutiques stables dépourvues d'antioxidant contenant des dérivés thiènopyridine
US20050053660A1 (en) * 2001-01-31 2005-03-10 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007011473A1 *

Also Published As

Publication number Publication date
WO2007011473A1 (fr) 2007-01-25
DE112006001548T5 (de) 2008-04-30
ES2326251B1 (es) 2010-07-08
EP1901718A1 (fr) 2008-03-26
CA2611938A1 (fr) 2007-01-25
ES2326251A1 (es) 2009-10-05

Similar Documents

Publication Publication Date Title
AP2008004547A0 (en) Petsticidal compositions
IL186721A0 (en) Bioenhanced compositions
EP1930012A4 (fr) Composition contenant un cello-oligosaccharide
GB0503337D0 (en) Compositions
ZA200705428B (en) Stable prostaglandin-containing compositions
IL186093A0 (en) Lignan-containing compositions
EP1865042A4 (fr) Composition anti-gel
EP1847249A4 (fr) Composition de coloration capillaire
GB0526283D0 (en) Compositions
GB0501365D0 (en) Compositions
ZA200709913B (en) Bioenhanced compositions
EP1947129A4 (fr) Composition à polymérisation photoradicalaire et photocationique
GB0508250D0 (en) Composition
EP1864573A4 (fr) Composition chimique agricole
GB0524128D0 (en) Compositions
GB0506044D0 (en) Composition
GB0507167D0 (en) Composition
EP1901718A4 (fr) Compositions de ticlopidine à diffusion modifiée
GB0526282D0 (en) Compositions
GB0502341D0 (en) Composition
GB0513641D0 (en) Anti-egeing composition
GB0501364D0 (en) Compositions
GB0510286D0 (en) Composition
GB0506065D0 (en) Compositions
GB0505989D0 (en) Compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ELAN PHARMA INTERNATIONAL LIMITED

A4 Supplementary search report drawn up and despatched

Effective date: 20120620

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/26 20060101AFI20120614BHEP

Ipc: A61K 9/14 20060101ALI20120614BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130103